BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19837406)

  • 1. Association of the single nucleotide polymorphism rs599839 in the vicinity of the sortilin 1 gene with LDL and triglyceride metabolism, coronary heart disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health Study.
    Kleber ME; Renner W; Grammer TB; Linsel-Nitschke P; Boehm BO; Winkelmann BR; Bugert P; Hoffmann MM; März W
    Atherosclerosis; 2010 Apr; 209(2):492-7. PubMed ID: 19837406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease.
    Linsel-Nitschke P; Heeren J; Aherrahrou Z; Bruse P; Gieger C; Illig T; Prokisch H; Heim K; Doering A; Peters A; Meitinger T; Wichmann HE; Hinney A; Reinehr T; Roth C; Ortlepp JR; Soufi M; Sattler AM; Schaefer J; Stark K; Hengstenberg C; Schaefer A; Schreiber S; Kronenberg F; Samani NJ; Schunkert H; Erdmann J
    Atherosclerosis; 2010 Jan; 208(1):183-9. PubMed ID: 19660754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sortilin and the risk of cardiovascular disease.
    Coutinho MF; Bourbon M; Prata MJ; Alves S
    Rev Port Cardiol; 2013 Oct; 32(10):793-9. PubMed ID: 23910371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk scores of common genetic variants for lipid levels influence atherosclerosis and incident coronary heart disease.
    Isaacs A; Willems SM; Bos D; Dehghan A; Hofman A; Ikram MA; Uitterlinden AG; Oostra BA; Franco OH; Witteman JC; van Duijn CM
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2233-9. PubMed ID: 23766260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association between Serum LDL Cholesterol and Genetic Variation in Chromosomal Locus 1p13.3 among Coronary Artery Disease Patients.
    Rizk NM; El-Menyar A; Egue H; Souleman Wais I; Mohamed Baluli H; Alali K; Farag F; Younes N; Al Suwaidi J
    Biomed Res Int; 2015; 2015():678924. PubMed ID: 25969834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LDL molecular size as risk factor in coronary artery disease.
    Kozma L; Fodor J; Chockalingam A; Sussex B
    Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorting out cholesterol and coronary artery disease.
    Linsel-Nitschke P; Samani NJ; Schunkert H
    N Engl J Med; 2010 Dec; 363(25):2462-3. PubMed ID: 21158662
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
    Petrovic D; Zorc M; Peterlin B
    Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol.
    Samani NJ; Braund PS; Erdmann J; Götz A; Tomaszewski M; Linsel-Nitschke P; Hajat C; Mangino M; Hengstenberg C; Stark K; Ziegler A; Caulfield M; Burton PR; Schunkert H; Tobin MD
    J Mol Med (Berl); 2008 Nov; 86(11):1233-41. PubMed ID: 18649068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic risk variants at 1p13.3, 1q41, and 3q22.3 are associated with subsequent cardiovascular outcomes in healthy controls and in established coronary artery disease.
    Ellis KL; Frampton CM; Pilbrow AP; Troughton RW; Doughty RN; Whalley GA; Ellis CJ; Skelton L; Thomson J; Yandle TG; Richards AM; Cameron VA
    Circ Cardiovasc Genet; 2011 Dec; 4(6):636-46. PubMed ID: 21984477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase gene Q192R & L55M polymorphisms in Indians with acute myocardial infarction & association with oxidized low density lipoprotein.
    Lakshmy R; Ahmad D; Abraham RA; Sharma M; Vemparala K; Das S; Reddy KS; Prabhakaran D
    Indian J Med Res; 2010 Apr; 131():522-9. PubMed ID: 20424303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.
    März W; Scharnagl H; Winkler K; Tiran A; Nauck M; Boehm BO; Winkelmann BR
    Circulation; 2004 Nov; 110(19):3068-74. PubMed ID: 15505088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study.
    Heiba IM; DeMeester CA; Xia YR; Diep A; George VT; Amos CI; Srinivasan SR; Berenson GS; Elston RC; Lusis AJ
    Am J Med Genet; 1993 Nov; 47(6):875-83. PubMed ID: 8279486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma triglyceride level and mortality from coronary heart disease.
    Criqui MH; Heiss G; Cohn R; Cowan LD; Suchindran CM; Bangdiwala S; Kritchevsky S; Jacobs DR; O'Grady HK; Davis CE
    N Engl J Med; 1993 Apr; 328(17):1220-5. PubMed ID: 8464432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of SNP rs17465637 on chromosome 1q41 and rs599839 on 1p13.3 with myocardial infarction in an American caucasian population.
    Wang AZ; Li L; Zhang B; Shen GQ; Wang QK
    Ann Hum Genet; 2011 Jul; 75(4):475-82. PubMed ID: 21463265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
    Wang C; Zhou X; Ye S; Han D; Tan X; Zheng F; Shi Q
    Int J Hyg Environ Health; 2006 May; 209(3):265-73. PubMed ID: 16459141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction.
    Nauck M; Winkelmann BR; Hoffmann MM; Böhm BO; Wieland H; März W
    J Mol Med (Berl); 2002 Aug; 80(8):507-13. PubMed ID: 12185451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.